Company Filing History:
Years Active: 2015-2018
Title: Sun-Joon Min: Innovator in Neurodegenerative Disease Research
Introduction
Sun-Joon Min is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented inventions. With a total of 2 patents, Min is recognized for his work in developing compounds that target critical biological processes.
Latest Patents
Min's latest patents include groundbreaking research on quinoline derivatives and benzoarylureido compounds. The first patent focuses on quinoline derivatives that inhibit the activity of histone methyltransferases, specifically targeting the histone molecule H3K9. This innovation has potential applications in various therapeutic areas. The second patent involves novel benzoarylureido compounds aimed at preventing or treating neurodegenerative brain diseases, including Alzheimer's disease, dementia, and Parkinson's disease. These compounds represent a significant advancement in the fight against debilitating neurological conditions.
Career Highlights
Sun-Joon Min is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential impact on the treatment of neurodegenerative diseases. Min's dedication to scientific advancement is evident in his innovative approach to drug development.
Collaborations
Min collaborates with esteemed colleagues, including Hoh-Gyu Hahn and Kee-Dal Nam. These partnerships enhance the research efforts and contribute to the development of effective treatments for neurodegenerative conditions.
Conclusion
Sun-Joon Min's contributions to the field of neurodegenerative disease research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative solutions in medicine.